宫颈癌患者放化疗期间全程营养管理研究进展

doi:10.11904/j.issn.1002-3070.2026.01.012

摘要/Abstract

摘要： 放化疗作为局部晚期宫颈癌的主要治疗方式之一,在提高患者生存率方面发挥了不可替代的作用。然而,接受放疗的宫颈癌患者营养不良发生率较高,这与肿瘤患者本身的代谢紊乱、治疗相关的不良反应以及患者心理状况等因素相关。营养不良会降低治疗耐受性,增加治疗中断的风险,甚至影响患者生存。因此,营养干预已成为抗肿瘤治疗的重要组成部分,应贯穿于放化疗的全程。但现阶段临床实践中,仅少数患者真正获得全面、充分的营养支持,建立规范化、连续性的全程营养管理体系具有重要临床意义。本文从宫颈癌患者的营养状况、预后、评估和干预等方面进行了综述,以期为临床工作提供参考。

关键词: 宫颈癌, 营养不良, 营养管理, 预后

Abstract: Chemoradiotherapy,as one of the main treatment methods for locally advanced cervical cancer,has played an irreplaceable role in improving patient survival rates.However,cervical cancer patients undergoing radiotherapy have a high incidence of malnutrition,which is related to factors such as metabolic disorders inherent to cancer patients,treatment-related adverse reactions,and patients` psychological conditions.Malnutrition can reduce treatment tolerance,increase the risk of treatment interruption,and even affect patient survival.Therefore,nutritional intervention has become an important component of anti-tumor treatment,and should be integrated throughout the entire process of chemoradiotherapy.However,in current clinical practice,only a small number of patients actually receive comprehensive and adequate nutritional support.Establishing a standardized and continuous nutritional management system throughout the entire process is of great clinical importance.This paper provides a review of the nutritional status,prognosis,assessment,and intervention of cervical cancer patients,aiming to provide a reference for clinical practice.

Key words: cervical cancer, malnutrition, nutritional management, prognosis

中图分类号:

R737.33

万萌, 朱丽红. 宫颈癌患者放化疗期间全程营养管理研究进展[J]. 实用肿瘤学杂志, 2026, 40(1): 83-88.

WAN Meng, ZHU Lihong. Research progress on comprehensive nutritional management during chemoradiotherapy for cervical cancer patients[J]. Journal of Practical Oncology, 2026, 40(1): 83-88.

参考文献

1 Bray F,Laversanne M,Sung H,et al.Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2024,74(3):229-263.
2 Printz C.Lower cervical cancer risk associated with HPV vaccine[J].Cancer,2021,127(8):1171.
3 中国抗癌协会妇科肿瘤专业委员会.子宫颈癌诊断与治疗指南(2021年版)[J].中国癌症杂志,2021,31(06):474-489.
4 Rubinsak LA,Kang L,Fields EC,et al.Treatment-related radiation toxicity among cervical cancer patients[J].Int J Gynecol Cancer,2018,28(7):1387-1393.
5 Sánchez M,Castro-Eguiluz D,Luvián-Morales J,et al.Deterioration of nutritional status of patients with locally advanced cervical cancer during treatment with concomitant chemoradiotherapy[J].J Hum Nutr Diet,2019,32(4):480-491.
6 Abe A,Yuasa M,Imai Y,et al.Extreme leanness,lower skeletal muscle quality,and loss of muscle mass during treatment are predictors of poor prognosis in cervical cancer treated with concurrent chemoradiation therapy[J].Int J Clin Oncol,2022,27(5):983-991.
7 Das U,Patel S,Dave K,et al.Assessment of nutritional status of gynecological cancer cases in India and comparison of subjective and objective nutrition assessment parameters[J].South Asian J Cancer,2014,3(1):38-42.
8 李群,石汉平,杨柳青.肿瘤患者的营养治疗[J].实用肿瘤学杂志,2024,38(06):417-420.
9 Aredes MA,Garcez MR,Chaves GV.Influence of chemoradiotherapy on nutritional status,functional capacity,quality of life and toxicity of treatment for patients with cervical cancer[J].Nutr Diet,2018,75(3):263-270.
10 Aredes MA,Garcez MR,Chaves GV.Skeletal muscle loss is an imaging biomarker of outcome after definitive chemoradiotherapy for locally advanced cervical cancer[J].Clin Cancer Res,2018,24(20):5028-5036.
11 王方,甄宏楠,于康,等.宫颈癌患者同步放化疗期间营养状况和人体成分变化[J].中华临床营养杂志,2025,33(02):81-89.
12 Laky B,Janda M,Bauer J,et al.Malnutrition among gynaecological cancer patients[J].Eur J Clin Nutr,2007,61(5):642-646.
13 Laan J,van Lonkhuijzen L,Hinnen K,et al.Malnutrition is associated with poor survival in women receiving radiotherapy for cervical cancer[J].Int J Gynecol Cancer,2024,34(4):497-503.
14 Kizer NT,Thaker PH,Gao F,et al.The effects of body mass index on complications and survival outcomes in patients with cervical carcinoma undergoing curative chemoradiation therapy[J].Cancer,2011,117(5):948-956.
15 Laan JJ,van Lonkhuijzen LRCW,van Os RM,et al.Socioeconomic status as an independent risk factor for severe late bowel toxicity after primary radiotherapy for cervical cancer[J].Gynecol Oncol,2017,147(3):684-689.
16 Lu L,Ji S,Jiang J,et al.Body weight is a valid predictor of the long-term prognosis of cervical cancer[J].Comput Math Methods Med,2022,2022:5613350.
17 Lim H,Kim SI,Kim MK,et al.Initial sarcopenia and body composition changes as prognostic factors in cervical cancer patients treated with concurrent chemoradiation:An artificial intelligence-based volumetric study[J].Gynecol Oncol,2024,190:200-208.
18 Li YW,Gao LG,Song HC,et al.Nutritional assessment of gynecological cancer patients in China[J].Journal of Nutritional Oncology,2017,2(3):145-152.
19 Jou J,Coulter E,Roberts T,et al.Assessment of malnutrition by unintentional weight loss and its implications on oncologic outcomes in patient with locally advanced cervical cancer receiving primary chemoradiation.Gynecol Oncol[J],2021,160(3):721-728.
20 Gaafer OU,Zimmers TA.Nutrition challenges of cancer cachexia[J].JPEN J Parenter Enteral Nutr,2021,45(S2):16-25.
21 Chen JL,Huang CY,Shih IL,et al.Prognostic nutritional index and neutrophil-lymphocyte ratio predict toxicities and prognosis in patients with cervical cancer treated with curative radiochemotherapy[J].J Formos Med Assoc,2024,123(6):671-678.
22 Giannotti C,Zoppoli G,Ferrando L,et al.Development of a predictor of one-year mortality in older patients with cancer by geriatric and oncologic parameters[J].J Geriatr Oncol,2020,11(4):610-616.
23 Corsello A,Pugliese D,Gasbarrini A,et al.Diet and nutrients in gastrointestinal chronic diseases[J].Nutrients,2020,12(9):2693.
24 Seid A,Debebe Z,Ayelign A,et al.Nutritional status and its determinants among adults with cancer prior to the initiation of chemotherapy:an ordinal regression analysis[J].Nutr Cancer,2025,77(9):1052-1064.
25 Loge L,Florescu C,Alves A,et al.Radiation enteritis:diagnostic and therapeutic issues[J].J Visc Surg,2020,157(6):475-485.
26 Keys HM,Bundy BN,Stehman FB,et al.Cisplatin,radiation,and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma[J].N Engl J Med,1999,340(15):1154-1161.
27 Arends J,Bachmann P,Baracos V,et al.ESPEN guidelines on nutrition in cancer patients[J].Clin Nutr,2017,36(1):11-48.
28 Muscaritoli M,Arends J,Bachmann P,et al.ESPEN practical guideline:Clinical nutrition in cancer[J].Clin Nutr,2021,40(5):2898-2913.
29 McIntyre CL,Temesgen A,Lynch L.Diet,nutrient supply,and tumor immune responses[J].Trends Cancer,2023,9(9):752-763.
30 Randeni N,Bordiga M,Xu B.A comprehensive review of the triangular relationship among diet-gut microbiota-inflammation[J].Int J Mol Sci,2024,25(17):9366.
31 Donaldson MS.Nutrition and cancer:a review of the evidence for an anti-cancer diet[J].Nutr J,2004,3:19.
32 Aredes MA,da Camara AO,de Paula NS,et al.Efficacy of ω-3 supplementation on nutritional status,skeletal muscle,and chemoradiotherapy toxicity in cervical cancer patients:A randomized,triple-blind,clinical trial conducted in a middle-income country[J].Nutrition,2019,67-68:110528.

[1]	左婷婷, 于志福, 申展, 王忱玉, 朱博. BMI对不同分子亚型女性乳腺癌患者预后影响的回顾性研究[J]. 实用肿瘤学杂志, 2026, 40(1): 41-47.
[2]	刘燕青, 张金丽. 2004—2021年中国女性宫颈癌疾病负担变化趋势分析[J]. 实用肿瘤学杂志, 2025, 39(6): 507-514.
[3]	李一凡, 秦川玉, 曾玺, 陆娅胶, 廖光东, 康乐妮, 杨英, 周敏, 郄明蓉, 杨春霞, 李静. 宫颈癌筛查人群对自取样尿液HPV检测的接受度及影响因素分析[J]. 实用肿瘤学杂志, 2025, 39(5): 412-417.
[4]	李旭东, 刘通. 单细胞转录组揭示PCLAF与ERO1A在乳腺癌进展中的作用及预后价值[J]. 实用肿瘤学杂志, 2025, 39(5): 418-427.
[5]	罗丹利, 李福程, 贾斯媛, 窦赫, 巴玉玲, 高天, 李照廷, 肖敏. 血浆动脉粥样硬化指数对新辅助化疗乳腺癌患者病理完全缓解率及预后的影响[J]. 实用肿瘤学杂志, 2025, 39(4): 316-323.
[6]	李勇, 刘冰梅. 构建基于染色质重塑相关基因的皮肤黑色素瘤预后预测模型[J]. 实用肿瘤学杂志, 2025, 39(2): 134-143.
[7]	王孟菲, 许波群. 局部晚期宫颈癌免疫治疗进展[J]. 实用肿瘤学杂志, 2025, 39(2): 157-161.
[8]	张华, 努尔比亚·依比布拉, 路鹏霏, 贾春丽, 裴轩萱, 包永星. CXCL8对宫颈癌细胞紫杉醇敏感性的影响及机制研究[J]. 实用肿瘤学杂志, 2025, 39(1): 13-20.
[9]	马铭, 王婉莹, 阮玉莉, 刘超, 张艳桥, 马志刚. 全身炎症免疫营养评分判断晚期胃癌免疫治疗预后的价值分析[J]. 实用肿瘤学杂志, 2025, 39(1): 39-48.
[10]	陈茂森, 文洪梅, 石青萍, 邵英, 唐娴, 任思颖, 陈杨. 2020年云南省肿瘤登记地区宫颈癌发病和死亡情况及2012—2020年趋势分析[J]. 实用肿瘤学杂志, 2024, 38(6): 355-360.
[11]	孙莉君, 董大伟. 基于铂类耐药相关基因的卵巢癌分型和预后研究[J]. 实用肿瘤学杂志, 2024, 38(3): 184-191.
[12]	廖俊, 李春峰, 薛英威, 祖洪亮. 乳酸脱氢酶在胃癌诊治中的研究进展[J]. 实用肿瘤学杂志, 2024, 38(3): 200-206.
[13]	周建云, 储巧香, 陆月梅, 朱静, 丁其培. lncRNA GAS5对宫颈癌细胞增殖、侵袭能力及PTEN/Akt/mTOR信号通路的影响[J]. 实用肿瘤学杂志, 2024, 38(2): 96-103.
[14]	杨鹏, 罗金梅, 罗萍, 谢小波. 基于免疫细胞浸润的免疫评分模型预测早期胃癌免疫治疗效果及预后[J]. 实用肿瘤学杂志, 2024, 38(2): 121-130.
[15]	高燕, 姚盟成, 李哲丰, 韩晓阳, 岳文涛. 单细胞测序数据揭示DMKN在卵巢癌中的诊断及预测价值[J]. 实用肿瘤学杂志, 2023, 37(6): 478-484.